Antimicrobial Agents Practice Questions

Q: A patient with multidrug-resistant tuberculosis, who is receiving antitubercular drugs, develops an inability to distinguish between red and green colors after a few months. Which antitubercular drug is most likely causing these symptoms?

Ethambutol. ***Ethambutol*** - **Ethambutol** is known to cause **optic neuritis**, which can manifest as **red-green color blindness** and decreased visual acuity [1]. - This adverse effect is typically dose-dependent and reversible upon discontinuation of the drug [1].*Rifampicin* - **Rifampicin** is associated with a variety of side effects including **hepatotoxicity**, **orange discoloration of body fluids**, and gastrointestinal upset, but not typically optic neuritis or color blindness. - While it is a potent antitubercular drug, its adverse effect profile does not include ophthalmological issues like those described.*Ethionamide* - **Ethionamide** is known for side effects such as **gastrointestinal disturbance**, **hepatotoxicity**, and **hypothyroidism**. - It can also cause psychiatric side effects and peripheral neuropathy, but not specifically red-green color vision impairment.*Cycloserine* - **Cycloserine** is primarily associated with **neuropsychiatric side effects**, including psychosis, depression, seizures, and peripheral neuropathy [2]. - It does not typically cause optic neuritis or color vision disturbances like those seen with ethambutol.

Q: According to current WHO guidelines, the first-line treatment for uncomplicated chloroquine-resistant falciparum malaria is:

Artemisinin-based combination therapy (ACT). ***Artemisinin-based combination therapy (ACT)*** - The World Health Organization (WHO) currently recommends **artemisinin-based combination therapies (ACTs)** as the first-line treatment for uncomplicated *Plasmodium falciparum* malaria, even in areas with chloroquine resistance. - ACTs are highly effective due to the **synergistic action** of artemisinin derivatives, which rapidly reduce parasite biomass, and a longer-acting partner drug that eliminates residual parasites, preventing recrudescence and resistance development. *Quinine* - While historically used for malaria, **quinine** is no longer the first-line treatment for uncomplicated *falciparum* malaria due to a **higher rate of treatment failure** and more side effects compared to ACTs. - It is often reserved for severe malaria or in cases where ACTs are contraindicated or unavailable. *Pyrimethamine* - **Pyrimethamine** is an antifolate drug that inhibits dihydrofolate reductase and is typically used in combination with sulfadoxine (as **Fansidar**). - Widespread **resistance** to pyrimethamine, particularly in *P. falciparum*, has made it largely ineffective as a standalone or first-line treatment for uncomplicated malaria. *Primaquine* - **Primaquine** is an 8-aminoquinoline derivative used to eliminate **hypnozoites** of *P. vivax* and *P. ovale* to prevent relapse, and as a gametocytocide for *P. falciparum* to reduce transmission. - It is **not effective** as a primary treatment for the asexual blood stages of *P. falciparum* that cause acute illness and therefore is not a first-line treatment for uncomplicated *falciparum* malaria.

Q: Third-generation cephalosporins include all of the following except:

Cefoxitin. ***Cefoxitin*** - **Cefoxitin** is a **second-generation cephalosporin**, primarily known for its activity against **anaerobic bacteria** (like *Bacteroides fragilis*) and certain **Gram-negative bacteria**. - Its spectrum of activity and chemical structure classify it distinctly from third-generation cephalosporins, which offer broader Gram-negative coverage and better penetration into the CNS. *Ceftizoxime* - **Ceftizoxime** is a **third-generation cephalosporin** with a broad spectrum of activity against many **Gram-negative bacilli** and some **Gram-positive cocci**. - It is often used for serious infections, including intra-abdominal and lower respiratory tract infections. *Cefoperazone* - **Cefoperazone** is another **third-generation cephalosporin** known for its activity against ***Pseudomonas aeruginosa***, a common feature of many third-generation agents. - It also provides good activity against other Gram-negative organisms, making it suitable for a range of severe infections. *Cefixime* - **Cefixime** is an **oral third-generation cephalosporin** commonly used for outpatient treatment of infections such as **otitis media**, **streptococcal pharyngitis**, and **uncomplicated urinary tract infections**. - Its oral bioavailability distinguishes it from many injectable third-generation cephalosporins but it shares the typical third-generation spectrum of activity.

Q: Which antimalarial drug is considered the safest during pregnancy?

Chloroquine. ***Chloroquine*** - **Chloroquine** is considered the **safest antimalarial drug during pregnancy** and is the drug of choice for malaria prophylaxis and treatment in pregnant women. - It has been used extensively for decades with an **excellent safety profile** across all trimesters, including the first trimester. - Classified as **FDA Pregnancy Category C**, chloroquine has extensive clinical data supporting its safety, with no significant teratogenic effects reported. - **WHO and CDC** both recommend chloroquine as the preferred antimalarial for pregnant women in chloroquine-sensitive malaria areas. - It is effective against **Plasmodium vivax** and chloroquine-sensitive **P. falciparum** strains. *Pyrimethamine* - **Pyrimethamine** is a **dihydrofolate reductase inhibitor** that interferes with folate metabolism, which is crucial during pregnancy for fetal neural tube development. - Should be used with **caution in the first trimester** due to risk of **folate deficiency** and potential teratogenicity. - When used (typically as sulfadoxine-pyrimethamine), it must be co-administered with **folic acid supplementation** to reduce risks. - Not considered first-line due to these concerns. *Proguanil* - **Proguanil** is relatively safe but is typically used in **combination therapy** (atovaquone-proguanil) rather than as monotherapy. - While it has a reasonable safety profile as a **dihydrofolate reductase inhibitor**, it has **less extensive safety data** during pregnancy compared to chloroquine. - Generally considered a **second-line option** when chloroquine-resistant malaria is present. - Often requires folate supplementation when used during pregnancy. *None of the options* - This is incorrect because **chloroquine** is definitively recognized as the safest antimalarial during pregnancy, with decades of safe use and endorsement by major health organizations including WHO and CDC.

Q: Nitazoxanide is specifically indicated for the treatment of which opportunistic infection in AIDS patients?

Cryptosporidiosis. ***Cryptosporidiosis*** - **Nitazoxanide** is an **antiprotozoal agent** specifically indicated for treating **cryptosporidiosis**, particularly in immunocompromised patients like those with AIDS. - It works by inhibiting the **pyruvate ferredoxin oxidoreductase enzyme pathway** in *Cryptosporidium parvum*, disrupting their energy metabolism. *Cryptococcosis* - **Cryptococcosis** is a fungal infection usually treated with **amphotericin B** and **flucytosine**, followed by fluconazole. - Nitazoxanide has **no significant activity** against *Cryptococcus neoformans*. *Histoplasmosis* - **Histoplasmosis** is a fungal infection primarily treated with **amphotericin B** for severe disease or **itraconazole** for milder forms. - Nitazoxanide is an **antiprotozoal** medication and is not effective against *Histoplasma capsulatum*. *Candidiasis* - **Candidiasis** is a fungal infection commonly treated with **fluconazole**, topical azoles, or other antifungal agents depending on the site and severity. - Nitazoxanide is **not indicated** for the treatment of **Candida infections**.

Q: Drugs that cross the placenta are:

All of the options. ***All of the options*** - **Isoniazid**, **rifampicin**, and **pyrazinamide** are all antitubercular drugs that cross the placenta. - This is the **most comprehensive answer** as it correctly identifies that all three listed drugs have placental transfer. - Important consideration for treating **tuberculosis in pregnancy**, as all three drugs are part of standard TB regimens and fetal exposure must be monitored. *Isoniazid (Incomplete answer)* - While **isoniazid** does cross the placenta, selecting only this option is incomplete as the other drugs also cross. - Can cause fetal **hepatotoxicity** and **peripheral neuropathy**; vitamin B6 supplementation is recommended. - Generally considered safe in pregnancy when treating active TB. *Rifampicin (Incomplete answer)* - **Rifampicin** crosses the placenta, but this option alone is incomplete. - May cause **neonatal hemorrhage** due to vitamin K deficiency; prophylactic vitamin K should be given to the neonate. - Safe for use in pregnancy for TB treatment. *Pyrazinamide (Incomplete answer)* - **Pyrazinamide** also crosses the placenta, making this option incomplete when selected alone. - Previously avoided in pregnancy due to limited data, but **WHO now recommends** its use in pregnancy as part of standard TB regimens. - Current evidence supports its safety profile in pregnancy.

Q: Which of the following statements about isavuconazonium sulfate is false?

Acts through blocking cytoplasmic proteins. ***Acts through blocking cytoplasmic proteins*** - Isavuconazonium sulfate, an azole antifungal, primarily acts by **inhibiting lanosterol 14-α-demethylase (CYP51)**, an enzyme crucial for fungal ergosterol synthesis. - This **disrupts fungal cell membrane integrity**, rather than blocking cytoplasmic proteins. - This is the **FALSE statement** - the mechanism is membrane-directed, not cytoplasmic protein-directed. *Effective against yeasts, molds, and dimorphic fungi* - Isavuconazonium sulfate is a **broad-spectrum triazole antifungal** effective against a wide range of fungal pathogens. - This includes common yeasts like *Candida* species, molds such as *Aspergillus* and *Rhizopus*, and various dimorphic fungi. *Approved for aspergillosis and mucormycosis* - This statement is true; isavuconazonium sulfate is indeed **FDA-approved for the treatment of invasive aspergillosis and mucormycosis**. - It provides an important therapeutic option for these serious and often life-threatening fungal infections. *Has minimal nephrotoxicity* - Isavuconazonium sulfate is notable for its **favorable renal safety profile** compared to amphotericin B and lacks the cyclodextrin vehicle present in IV voriconazole. - Studies have shown a **low incidence of nephrotoxicity**, making it a preferred choice in patients with impaired renal function or those at risk of kidney injury.

Q: Which of the following drugs causes pseudotumour cerebri?

Tetracycline. ***Tetracycline*** - **Tetracyclines** are a well-known cause of **pseudotumor cerebri**, also called idiopathic intracranial hypertension. - This condition involves increased **intracranial pressure**, leading to symptoms like headaches, visual disturbances, and papilledema. *Sparfloxacin* - **Sparfloxacin** is a **fluoroquinolone antibiotic** primarily associated with phototoxicity and QTc prolongation. - It is not typically linked to the development of **pseudotumor cerebri**. *Gentamicin* - **Gentamicin** is an **aminoglycoside antibiotic** known for its ototoxicity and nephrotoxicity. - It does not cause **pseudotumor cerebri**. *Clofazimine* - **Clofazimine** is an **antimycobacterial drug** used in leprosy, and its primary side effects include skin discoloration and gastrointestinal issues. - It is not associated with **pseudotumor cerebri**.

Q: Which of the following anti-TB drugs acts on extracellular organisms and is a bactericidal drug?

Streptomycin. ***Streptomycin*** - Streptomycin is an **aminoglycoside antibiotic** that acts primarily on **extracellular, rapidly multiplying *Mycobacterium tuberculosis***. - It is a **bactericidal drug** that inhibits protein synthesis by binding to the 30S ribosomal subunit. *Isoniazid* - While **highly bactericidal**, isoniazid primarily targets **intracellular** and rapidly growing *M. tuberculosis* by inhibiting **mycolic acid synthesis**. - Its activity is prominent against **intracellular organisms** found within macrophages. *Ethambutol* - Ethambutol is a **bacteriostatic drug** that prevents the formation of the **mycobacterial cell wall** by inhibiting arabinosyl transferase. - It works against both **extracellular and intracellular organisms** but is not the most potent bactericidal drug against extracellular forms. *Rifampicin* - Rifampicin is a **bactericidal drug** that inhibits **RNA synthesis** by binding to DNA-dependent RNA polymerase. - It is effective against both **extracellular and intracellular organisms** but also has good sterilizing activity against dormant bacilli, unlike streptomycin which is primarily extracellular.

Q: What is the treatment of choice for a gonococcal infection that is resistant to penicillin?

Ceftriaxone. ***Ceftriaxone*** - **Ceftriaxone** is the recommended first-line treatment for uncomplicated gonococcal infections, especially given increasing resistance to other antibiotics like penicillin. - It is a **third-generation cephalosporin** that targets the bacterial cell wall synthesis effectively. *Penicillin* - **Penicillin** is no longer the recommended treatment for gonorrhea due to widespread resistance, primarily mediated by **beta-lactamase production** by *Neisseria gonorrhoeae*. - Treating with penicillin when resistance is present would lead to treatment failure and continued transmission. *Ceftazidime* - **Ceftazidime** is a third-generation cephalosporin with activity against gram-negative organisms. - However, its activity against *Neisseria gonorrhoeae* is not considered first-line or superior to ceftriaxone, which has better pharmacokinetic properties for treating gonorrhea. *Spectinomycin* - **Spectinomycin** is an alternative treatment for gonococcal infections, particularly in individuals with severe allergy to cephalosporins or in regions where ceftriaxone resistance is emerging. - However, it is not the treatment of choice in regions where ceftriaxone is effective and available.

Question 1

A patient with multidrug-resistant tuberculosis, who is receiving antitubercular drugs, develops an inability to distinguish between red and green colors after a few months. Which antitubercular drug is most likely causing these symptoms?

Accepted Answer

Ethambutol

Answer

Rifampicin

Answer

Ethionamide

Answer

Cycloserine

Question 2

According to current WHO guidelines, the first-line treatment for uncomplicated chloroquine-resistant falciparum malaria is:

Accepted Answer

Artemisinin-based combination therapy (ACT)

Answer

Quinine

Answer

Pyrimethamine

Answer

Primaquine

Question 3

Third-generation cephalosporins include all of the following except:

Accepted Answer

Cefoxitin

Answer

Cefoperazone

Answer

Cefixime

Answer

Ceftizoxime

Question 4

Which antimalarial drug is considered the safest during pregnancy?

Accepted Answer

Chloroquine

Answer

Pyrimethamine

Answer

None of the options

Answer

Proguanil

Question 5

Nitazoxanide is specifically indicated for the treatment of which opportunistic infection in AIDS patients?

Accepted Answer

Cryptosporidiosis

Answer

Cryptococcosis

Answer

Histoplasmosis

Answer

Candidiasis

Question 6

Drugs that cross the placenta are:

Accepted Answer

All of the options

Answer

Isoniazid

Answer

Rifampicin

Answer

Pyrazinamide

Question 7

Which of the following statements about isavuconazonium sulfate is false?

Accepted Answer

Acts through blocking cytoplasmic proteins

Answer

Effective against yeasts, molds, and dimorphic fungi

Answer

Has minimal nephrotoxicity

Answer

Approved for aspergillosis and mucormycosis

Question 8

Which of the following drugs causes pseudotumour cerebri?

Accepted Answer

Tetracycline

Answer

Sparfloxacin

Answer

Gentamicin

Answer

Clofazimine

Question 9

Which of the following anti-TB drugs acts on extracellular organisms and is a bactericidal drug?

Accepted Answer

Streptomycin

Answer

Isoniazid

Answer

Ethambutol

Answer

Rifampicin

Question 10

What is the treatment of choice for a gonococcal infection that is resistant to penicillin?

Accepted Answer

Ceftriaxone

Answer

Penicillin

Answer

Ceftazidime

Answer

Spectinomycin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?